Femtech Market Share 2032: Leading Product Categories and Market Penetration
According to Fortune Business Insights, the global femtech market was valued at USD 7.81 billion in 2024. The market is projected to grow from USD 9.12 billion in 2025 to USD 28.89 billion by 2032, exhibiting a CAGR of 17.9% during the forecast period. In 2024, North America dominated the femtech market with a market share of 53.64%.

The Femtech market focuses on technology-driven products and services tailored to women’s health—covering areas like fertility tracking, menstruation, pregnancy & nursing, menopausal care, and general wellness. It includes mobile applications, wearable devices, diagnostics, and software platforms designed specifically for women’s unique healthcare needs. With increasing awareness, rising funding, and rapid technological advancements (e.g., AI-powered tools and precision wearables), the market is growing quickly, especially in North America and Asia-Pacific. As efforts continue to improve privacy, efficacy, and inclusivity, femtech is reshaping the future of women’s health.

According to Fortune Business Insights, the global femtech market was valued at USD 7.81 billion in 2024. The market is projected to grow from USD 9.12 billion in 2025 to USD 28.89 billion by 2032, exhibiting a CAGR of 17.9% during the forecast period. In 2024, North America dominated the femtech market with a market share of 53.64%.

Top Companies in the Femtech Market

  • Flo Health Inc. (U.K.)
  • Chiaro Technology Limited (U.K.)
  • Natural Cycles USA Corp (U.S.)
  • BioWink GmbH (Germany)
  • FemTec Health (U.S.)
  • Glow, Inc. (U.S.)
  • HeraMed (Israel)
  • Joylux, Inc. (U.S.)
  • Coroflo Ltd. (Ireland)

Key Industry Development – May 2025

May 2025 witnessed a significant milestone with the launch of Sara, a secure period-tracking app, by Comma—a female-founded startup. The announcement was backed by a successful USD 2 million seed round aimed at bolstering brand presence and trust in digital menstrual care.

Market Drivers & Restraints

Driving Growth

  • Rising R&D and Tech Adoption: Increased use of AI and machine learning in devices and apps is fueling market adoption .
  • Awareness & Investment: Greater focus on women's health and higher VC funding—Femtech startups founded by women secure ~28% of UK venture capital .
  • Corporate Support: Many employers now include Femtech services (e.g., digital reproductive health support) in benefits packages.

Constraints

  • Access Barriers in Emerging Regions: High costs, limited infrastructure, and cultural stigma in countries like India and China limit reach .
  • Funding Disparities: Despite making up nearly half the population, women's health attracts only ~4% of healthcare R&D funding .
  • Data Privacy Concerns: As Femtech apps collect sensitive health data, cybersecurity and regulatory compliance challenges are rising .

Market Report Coverage

The Fortune Business Insights report provides a granular analysis from 2019 to 2032, covering:

  • Market size & forecast
  • Segment-by-segment analysis (Type, Application, Region)
  • Trends: AI, wearable devices, blockchain, menopause-care tools
  • Impact of COVID-19
  • Regulatory landscape
  • Top company profiles & recent developments

Competitive Landscape

The Femtech industry exhibits high fragmentation, featuring both startups and established players. Companies such as Flo Health, Natural Cycles, and Glow continuously innovate and raise substantial funding—Natural Cycles secured USD 55 million in May 2024 for product expansions . Chiaro, Joylux, and Coroflo are also introducing new wearable and digital health solutions to strengthen their market share.

Market Segments

By Type

  • Mobile Applications: Accounted for the largest market share in 2024, driven by widespread smartphone use and funding toward app development .
  • Products (Wearables & Devices): Rising in popularity, especially for monitoring fertility, pregnancy, and menopause.

By Application

  • Menstruation Care & Fertility Tracking: Fastest-growing segment.
  • Pregnancy & Nursing Care: Largest share in 2024, thanks to increased wearable adoption for remote maternal health .
  • Menopausal Health: A growing area, with a global demographic of over 1.2 billion menopausal/postmenopausal women by 2030 .
  • General Health & Wellness: Offers mental health support, hormone balance, and lifestyle tracking.

Regional Insights

North America (53.64% share in 2024)

Dominates the market with strong investments, startups, and digital health adoption .

Europe

Holds the second-largest position, driven by rising funding and initiatives supporting women's health tech .

Asia-Pacific

Projected to showcase the highest CAGR with opportunities in India, China, and Japan .

Rest of World (Latin America, MEA)

Steady growth expected as smartphone penetration increases and health startup ecosystems develop .

Emerging Trends

  • AI & Machine Learning: Personalized fertility, menstrual cycle predictions, and symptom management tools.
  • Wearables Expansion: New devices like wearable breast pumps and hormone trackers launched by Elvie and others .
  • Blockchain Use: Implemented to secure and empower user-controlled health data.
  • Menopause Tech: Increasing focus on symptom-tracking solutions targeting peri- and post-menopausal women.
  • Digital Therapeutics: Apps offering mental health, sexual wellness, and chronic condition support for women.

Privacy & Security Concerns

While Femtech thrives on sensitive personal data, privacy and cybersecurity issues remain critical. Recent scholarly research highlights inadequate protections and tracking vulnerabilities in many mainstream apps . Addressing these concerns is essential for sustainable industry growth.

Explore the full research report with detailed insights and TOC:https://www.fortunebusinessinsights.com/femtech-market-107413 

Future Market Scope

The Femtech market’s trajectory appears strong. Sustained growth will be driven by:

  • Expanding digital health coverage in emerging nations
  • Leadership from startups backed by strong VC funding
  • Regulatory clarity on data security frameworks
  • Innovation in personalized diagnostics and wearable solutions

Expert insights recommend startups adopt hybrid business models—combining app subscriptions, device sales, B2B partnerships, and insurance integrations—to maximize market reach and resilience. Furthermore, establishing global regulatory standards and privacy safeguards will support cross-border scalability.

Conclusion

The global Femtech market is entering a high-growth phase, bolstered by technological innovation, rising awareness of women’s health needs, and shifting healthcare paradigms. With projections nearing USD 28.89 billion by 2032, the industry presents expansive opportunities across products, apps, and regions. Successfully addressing access, privacy, and regulatory challenges will enable startups and established players to realize the full potential of this transformative sector — improving women’s lives while delivering substantial market returns.

About Us:
Fortune Business Insights provides expert corporate analysis and accurate data, enabling businesses of all sizes to make timely decisions. We offer customized solutions tailored to each client’s needs, helping them address unique challenges. Our goal is to empower clients with holistic market intelligence and offer granular insights into the market they operate in.

Our reports are a blend of quantitative and qualitative analysis, aimed at helping businesses achieve sustainable growth. Our experienced analysts and consultants use leading research methodologies to provide comprehensive market assessments enriched with relevant data.

At Fortune Business Insights, we aim to highlight growth opportunities for our clients, offering insights and recommendations that help them navigate technological and market changes. Our consulting services are designed to help companies uncover hidden opportunities and address competitive challenges.

Contact us:

Fortune Business Insights™ Pvt.

Phone: USA: +1 833 909 2966 (Toll-Free),

United Kingdom: +44 808 502 0280 (Toll-Free),

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com

disclaimer

What's your reaction?